Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients: Relationship with insulin resistance

Diabetes Care

Volumn 20, Issue 4, 1997, Pages 627-631

  Bonora, Enzo ^a,d   Tessari, Roberto ^b   Micciolo, Rocco ^c   Zenere, Marina ^a   Targher, Giovanni ^a   Padovani, Roberto ^b   Falezza, Giancarlo ^b   Muggeo, Michele ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Negrar Hospital   (Italy)

^c UNIVERSITY OF TRENTO   (Italy)

^d UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETIC ANGIOPATHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; RISK FACTOR; TUNICA MEDIA;

EID: 0030940113     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.4.627     Document Type: Article

References (45)

1. Welborn TA, Wearne K: Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentration. Diabetes Care 2:154-160, 1979
2. Pyorala K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2:131-141, 1979
3. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G: Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-age population. Diabetologia 19:205-210, 1980
4. Cullen K, Stenhouse NS, Wearne KL, Welborn TA: Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia: 13-year study. J Chron Dis 36:371-377, 1983
5. Pyorala K, Savolainen E, Kaukola S, Haapakoski J: Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study Population. Acta Med Scand 701 (Suppl.):38-52, 1985
6. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, Eschwege E: Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia 34:356-361, 1991
7. Welborn TA, Knuiman MW, Ward N, Whittal DE: Serum insulin is a risk marker for coronary heart disease mortality in men but not in women. Diabetes Res Clin Pract 26:51-59, 1994
8. Wingard DL, Barrett-Connor EL, Ferrara A: Is insulin really a heart disease risk factor? Diabetes Care 18:1299-1304, 1995
9. Fontbonne AM, Eschwege EM: Insulin and cardiovascular disease. Paris Prospective Study. Diabetes Care 14:461-469, 1991
10. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957, 1996
11. Stout RW: Insulin and atheroma. 20-year perspective. Diabetes Care 13:631-654, 1990
12. DeFronzo RA: The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667-687, 1988
13. Reaven GM: Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
14. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
15. Laakso M, Sarlund H, Salonen R, Suhonen M, Pyorala K, Salonen JT, Karhapaa P: Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb 11:1068-1076, 1991
16. Shinozaki K, Suzuki M, Ikebuchi M, Hara Y, Harano Y: Demonstration of insulin resistance in coronary heart disease documented with angiography. Diabetes Care 19:1-7, 1996
17. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R: Intimai plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 74:1399-1406, 1986
18. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
19. World Health Organization: Arterial Hypertension: Report of a WHO Study Group. Geneva, World Health Org., 1978, p. 9-17 (Tech. Rep. Ser., no. 628)
20. Bonora E, Moghetti P, Zancanaro C, Cigolini M, Querena M, Cacciatori V, Corgnati A, Muggeo M: Estimates of in vivo insulin action in man: comparison of insulin tolerance tests and euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 68:374-378, 1989
21. Akinmokun A, Selby PL, Ramaiya K, Alberti KGMM: The short insulin tolerance test for determination of insulin sensitivity: a comparison with the euglycemic clamp. Diabet Med 9:432-437, 1992
22. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 18:499-502, 1972
23. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Summary of the second report of the National Cholesterol Education Program (NCEP). JAMA 269:3015-3023, 1993
24. Consensus Conference: Treatment of hypertriglyceridemia. JAMA 251:1196-1201, 1984
25. Orchard TJ, Becker DJ, Bates M, Kuller LH, Drash AL: Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol 118:326-337, 1983
26. Modan M, Halkin H, Almong S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z: Hyperinsulinemia. A link between hypertension, obesity and glucose intolerance. J Clin Invest 75:809-817, 1985
27. Bonora E, Zavaroni I, Alpi O, Pezzarossa A, Bruschi F, Dall'Aglio E, Guerra L, Coscelli C, Buttunni U: Relationship between blood pressure and plasma insulin in nonobese and obese nondiabetic subjects. Diabetologia 30:719-723, 1987
28. Vague P, Juhan-Vague I, Aillaud MF, Badier C, Viard R, Alessi MC, Collen D: Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level and relative body weight in normal and obese subjects. Metabolism 35:250-253, 1986
29. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, Reaven G: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:703-706, 1989
30. Ferrannini E, Haffner SM, Mitchell BD, Stern MP: Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416-422, 1991
31. Haffner SM, Valdez RA, Hazuda HH, Mitchell BD, Morales PA, Stern MP: Prospective analysis of the insulin resistance syndrome (syndrome X). Diabetes 41:715-722, 1992
32. Folsom AR, Eckfeldt JH, Weitzman S, Jing M, Chambless LE, Barnes RW, Cram KB, Hutchinson RG: Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke 25:66-73, 1994
33. Inchiostro S, Bertoli G, Zanette G, Donadon V: Evidence of higher insulin resistance in NIDDM patients with ischaemic heart disease. Diabetologia 37:597-603, 1994
34. Young MH, Yeng CY, Sheu WHH, Shieh SM, Fuh MMT, Chen YDI, Reaven GM: Insulin resistance, glucose intolerance, hyperinsulinemia and dyslipidemia in patients with angiographically demonstrated coronary artery disease. Am J Cardiol 72:458-460, 1993
35. Ley CJ, Swan J, Godsland IF, Walton C, Crook D, Stevenson JC: Insulin resistance, lipoproteins, body fat and hemostasis in nonobese men with angina and normal or abnormal coronary angiogram. J Am Coll Cardiol 23:377-383, 1994
36. Kawamori R, Yamasaki Y, Matsushima H, Nishizawa H, Nao K, Hougaku H, Maeda H, Handa N, Matsumoto M, Kamada T: Prevalence of carotid atherosclerosis in diabetic patients. Ultrasound high-resolution B-mode imaging of carotid arteries. Diabetes Care 15:1290-1294, 1992
37. Pujia A, Gnasso A, Irace C, Colonna A, Mattioli PL: Common carotid arterial wall thickness in NIDDM subjects. Diabetes Care 17:1330-1336, 1994
38. Salonen R, Salonen JT: Determinants of carotid intima-media thickness: a population-based ultrasonography study on Eastern Finnish men. J Intern Med 229:225-231, 1991
39. Welin L, Svardsudd K, Wilhelmssen L, Larsson B, Tibblin G: Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med 317:521-526, 1987
40. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R for the Insulin Resistance and Atherosclerosis Study Investigators: Insulin sensitivity and atherosclerosis. Circulation 93:1809-1817, 1996
41. Reaven GM, Chen YDI: Insulin resistance, its consequences and coronary heart disease. Must we choose one culprit? Circulation 93:1780-1783, 1996
42. Draznin B, Sussman KE, Eckel RH, Kao M, Yost T, Sherman NA: Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia. J Clin Invest 82:1848-1852, 1988
43. Phair RD: Cellular calcium and atherosclerosis: a brief review. Cell Calcium 9:275-284, 1989
44. Levy J, Gavin JR III, Sowers JR: Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med 96:260-273, 1994
45. Trovati M, Mularoni EM, Burzacca S, Ponziani MC, Massucco P, Mattiello L, Piretto V, Cavalot F, Anfossi G: Impaired insulin-induced platelet anti-aggregating effect in obesity and obese NIDDM patients. Diabetes 44:1318-1322, 1995